patent: search

DP6946 Patent Thickets and the Market for Innovation: Evidence from Settlement of Patent Disputes

We study how fragmentation of patent rights (‘patent thickets’) and the formation of the Court of Appeal for the Federal Circuit (CAFC) affected the duration of patent disputes, and thus the speed of technology diffusion through licensing. We develop a model of patent litigation which predicts faster settlement agreements when patent rights are fragmented and when there is less uncertainty about court outcomes, as was associated with the ‘pro-patent shift’ of CAFC. The model also predicts that the impact of fragmentation on settlement duration should be smaller under CAFC. We confirm these predictions empirically using a dataset that covers nearly all patent suits in U.S. federal district courts during the period 1975-2000. Finally, we analyze how fragmentation affects total settlement delay, taking into account both reduction in duration

Patent Lawsuit Silly Season: TechCrunch Sued For Patent Infringement After Critical Blog Post

There are different levels of ridiculousness when it comes to patent lawsuits, with the lowest of the low being patent lawsuits based more on spite than on any legitimate claim. For a while, it seemed like Ray Niro's use of the infamous JPG patent, to sue a bunch companies he just didn't like, was perhaps alone in that category. But, it appears that we now have a new entrant. Apparently, some company (who we won't even name, since there's a good chance it's doing this just to get press attention) sued a more well-known competitor for patent infringement, over a location-based services patent. Looking over the patent itself it's difficult to see how it was approved. People were talking about location-based profile matching a decade ago, let alone five years ago when this patent was filed.

Patent licensing after the Quanta decision

Patent owners have turned their attention to the terms and conditions of patent licenses now that the Supreme Court has recently expanded the scope of patent exhaustion through its Quanta Computer v. LG Electronics decision. "Patent exhaustion" is a term of art that generally means a patent owner can profit from the sale of a product covered by the patent only until the first sale of the product.

Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM)

announced today the issuance of U.S. Patent No. 7,410,978 (the "'978 patent"), entitled "Once Daily Dosage Forms of Trospium," which is licensed exclusively to the Company by the patent's assignee, Supernus Pharmaceuticals, Inc. The '978 patent covers the Company's approved product, SANCTURA XR(TM), a once-a-day formulation of trospium chloride which is indicated for the treatment of symptoms of an overactive bladder. Based on calculations made by the United States Patent and Trademark Office, the term of the '978 patent is twenty years plus 89 days from its filing date of November 4, 2004, or February 1, 2025. In September 2007, the Company entered into an agreement with Allergan, Inc. by which the Company granted Allergan an exclusive sublicense to market SANCTURA XR in the United States.

Environmental Control Corporation Acquires European Patent

It is with great pleasure that Environmental Control Corporation ("EVCC") (OTCBB: EVCC) announces the approval of its European Patent. The Reverse Flow Catalytic Muffler, European Patent # 1,488,083 has been granted in the following countries: Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Portugal, Spain, Sweden and the United Kingdom. Other intellectual property currently held by EVCC include two U.S. Patents: The Reverse Flow Catalytic Muffler (U.S. Patent #7,018,590) and The Combined Catalytic Muffler (U.S. Patent # 6,622,482); and two Canadian Patents: The Combined Catalytic Muffler (CDN Patent # 2,448,742) and The Reverse Flow Catalytic Muffler (CDN Patent # 2,448,648).

Environmental Control Corporation Acquires European Patent

VANCOUVER, BC -- (Marketwire) -- 09/08/08 -- It is with great pleasure that Environmental Control Corporation ("EVCC") (EVCC) announces the approval of its European Patent. The Reverse Flow Catalytic Muffler, European Patent # 1,488,083 has been granted in the following countries: Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Portugal, Spain, Sweden and the United Kingdom. Other intellectual property currently held by EVCC include two U.S. Patents: The Reverse Flow Catalytic Muffler (U.S. Patent #7,018,590) and The Combined Catalytic Muffler (U.S. Patent # 6,622,482); and two Canadian Patents: The Combined Catalytic Muffler (CDN Patent # 2,448,742) and The Reverse Flow Catalytic Muffler (CDN Patent # 2,448,648).

Environmental Control Corporation Acquires European Patent

VANCOUVER, BC -- 09/08/08 -- It is with great pleasure that Environmental Control Corporation ("EVCC") (OTCBB: EVCC) announces the approval of its European Patent. The Reverse Flow Catalytic Muffler, European Patent # 1,488,083 has been granted in the following countries: Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Portugal, Spain, Sweden and the United Kingdom. Other intellectual property currently held by EVCC include two U.S. Patents: The Reverse Flow Catalytic Muffler (U.S. Patent #7,018,590) and The Combined Catalytic Muffler (U.S. Patent # 6,622,482); and two Canadian Patents: The Combined Catalytic Muffler (CDN Patent # 2,448,742) and The Reverse Flow Catalytic Muffler (CDN Patent # 2,448,648).

Health Discovery Corporation Inks Agreement with Patent Profit International for Monetization of Patent Portfolio

Health Discovery Corporation (HDVY), a leader in support vector machine (SVM) based molecular diagnostic and prognostic test development today announced the signing of an Agreement with Patent Profit International (PPI), a Silicon Valley-based patent brokerage firm, with the goal of exploiting the full monetization potential of HDC's extensive pioneering patent portfolio. Under the agreement, PPI will market HDC's patent portfolio, which includes exclusive rights to SVM techniques and applications that reach far beyond biomarker discovery and the Healthcare Field, to prospective buyers/licensees in a wide range of technologies, including, but not limited to, information technology such as Internet browsers and search engines, spam mail detection, oil exploration, homeland security, and the automotive industry.

Health Discovery Corporation Inks Agreement with Patent Profit International for Monetization of Patent Portfolio

Health Discovery Corporation (OTCBB:HDVY), a leader in support vector machine (SVM) based molecular diagnostic and prognostic test development today announced the signing of an Agreement with Patent Profit International (PPI), a Silicon Valley-based patent brokerage firm, with the goal of exploiting the full monetization potential of HDC's extensive pioneering patent portfolio. Under the agreement, PPI will market HDC's patent portfolio, which includes exclusive rights to SVM techniques and applications that reach far beyond biomarker discovery and the Healthcare Field, to prospective buyers/licensees in a wide range of technologies, including, but not limited to, information technology such as Internet browsers and search engines, spam mail detection, oil exploration, homeland security, and the automotive industry.

Health Discovery Corporation Inks Agreement with Patent Profit International for Monetization of Patent Portfolio

SAVANNAH, Ga. - (Business Wire) Health Discovery Corporation (OTCBB:HDVY), a leader in support vector machine (SVM) based molecular diagnostic and prognostic test development today announced the signing of an Agreement with Patent Profit International (PPI), a Silicon Valley-based patent brokerage firm, with the goal of exploiting the full monetization potential of HDC's extensive pioneering patent portfolio. Under the agreement, PPI will market HDC's patent portfolio, which includes exclusive rights to SVM techniques and applications that reach far beyond biomarker discovery and the Healthcare Field, to prospective buyers/licensees in a wide range of technologies, including, but not limited to, information technology such as Internet browsers and search engines, spam mail detection, oil exploration, homeland security, and the automotive

Health Discovery Corporation Inks Agreement with Patent Profit International for Monetization of Patent Portfolio

SAVANNAH, Ga. (Business Wire) -- Health Discovery Corporation (OTCBB:HDVY), a leader in support vector machine (SVM) based molecular diagnostic and prognostic test development today announced the signing of an Agreement with Patent Profit International (PPI), a Silicon Valley-based patent brokerage firm, with the goal of exploiting the full monetization potential of HDC's extensive pioneering patent portfolio. Under the agreement, PPI will market HDC's patent portfolio, which includes exclusive rights to SVM techniques and applications that reach far beyond biomarker discovery and the Healthcare Field, to prospective buyers/licensees in a wide range of technologies, including, but not limited to, information technology such as Internet browsers and search engines, spam mail detection, oil exploration, homeland security, and the automotive

Ex parte Reexamination and Nanotechnology.

We should not take for granted that just because a patent has issued it is valid. Patent validity may be resolved in a reexamination process and anyone can request it. When a patent owner becomes aware of a problematic reference that may have an impact on the validity of a patent, he or she can bring that prior art and propose amendments to get around the prior art to the attention of the U.S. Patent and Trademark Office (PTO) to get a second review of the patent and hopefully a second stamp of approval. It is more difficult to break a patent in court if the PTO has already examined the prior art. The major advantage in choosing to seek a reexamination over litigation is that the reexamination costs in terms of time and money are much lower.

EU Patent Staff Go On Strike

h4rm0ny writes "Last Friday, staff at the European Patent Office went on strike. They protested outside for several hours and issued a statement claiming that 'the organisation is decentralising and focusing on granting as many patents as possible to gain financially from fees generated.' They also declared this as being disastrous for innovation and that their campaign was not for better wages, but for better quality patents. Meanwhile, n article on it discusses the US's own approach to dealing with the increasing flood of patent applications: a community patent project to help identify prior art. It might sound like a grass-roots scheme, and maybe it is, but those roots include such patent behemoths as IBM. So it looks like on both sides of the Atlantic, some signs of sanity might be emerging in the patent world from those people right

X1 Gains Patent

Pasadena-based X1 Technologies, which develops enterprise search software, said Monday that it has received a patent for technology in its products. According to the firm, it received U.S Patent 7,424,510, entitled "Methods and Systems for Web Based Incremental Searches," covering its method of displaying search results. The patent names Idealab's Bill Gross and Steven Lee Colwell as inventors, and was originally filed by the firm in September of 2003. The patent is behind X1's incremental search technology, which refines searches as a user types in each character of their search. The patent filing was made for X1 Technologies by Knobbe Martens Olson & Bear, LLP. X1 Technologies develops enterprise search software for finding documents, emails, and other related information.

Microsoft Sued Over User Editable Toolbar Patent

If you follow the patent world, you know of Gary Odom, who is known as The Patent Hawk. To say he's a big supporter of the patent system would be something of an understatement. He's been known to comment here on occasion, employing the style seen all-too-often among patent system apologists commenting on Techdirt posts: insult repeatedly and broadly, offer no actual points, refuse to actually counter anything we say, provide absolutely no evidence and (for good measure) insult again. However, as reader Jon has pointed out to us, Odom recently received a new patent (he's got a bunch) on tool group manipulations and he's now suing Microsoft for the way its toolbars work in Office 2007.

EFF Challenges Another Bogus Online Music Patent

The EFF's patent busting project continues, as it's filed a challenge against an online music patent held by a company named Seer Systems. The challenge includes plenty of prior art, including some published by the patent holder in a book, long before the patent application was actually filed. It's great to see the EFF continue to try to mow down these patents one by one, but it's worth noting how slow and cumbersome this process has been. The EFF first announced its patent busting project more than four years ago. And, while the program has had successes, it's been very slow going. If it takes this long to bust such obviously bad patents, just think of the trouble dealing with ones that aren't quite as obviously bad.

Surfware, Inc. Announces U.S. Patent Office Notice of Allowance for Engagement Milling...

Surfware, Inc. Announces U.S. Patent Office Notice of Allowance for Engagement Milling (TrueMill) CAMARILLO, Calif., Aug. 19 /PRNewswire/ -- Surfware, Inc., developer of innovative CAD/CAM software for machining, announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its Engagement Milling technology. A Notice of Allowance signifies that the application has been examined and is allowed for issuance as a patent. The U.S. Patent Office accepted all key aspects of the company's patent application. "We are pleased to receive this Notice of Allowance because it serves to protect the intellectual property and proprietary technology that we have developed," says Stephen Diehl, President and CEO of Surfware.

Residential Cruise Line Receives USA Design Patent

PHOENIX, Sept. 24 /PRNewswire/ -- Randall B. Jackson, chief executive officer of Residential Cruise Line Ltd. (RCL) announces the Company has received a United States Design Patent for the Magellan, the world's largest residential cruise ship. Patent number US D570,277 S was issued to Randall Jackson on June 3, 2008. According to the Director of the United States Patent and Trademark Office, the patent protects the ship's design from others making, using, offering for sale or selling the design throughout the United States or importing the design into the United States for fourteen years from the date of the grant of the patent.

Residential Cruise Line Receives USA Design Patent

PHOENIX -- Randall B. Jackson, chief executive officer of Residential Cruise Line Ltd. (RCL) announces the Company has received a United States Design Patent for the Magellan, the world's largest residential cruise ship. Patent number US D570,277 S was issued to Randall Jackson on June 3, 2008. According to the Director of the United States Patent and Trademark Office, the patent protects the ship's design from others making, using, offering for sale or selling the design throughout the United States or importing the design into the United States for fourteen years from the date of the grant of the patent.

CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved

a technology management company, announced the company has received approval of its fifth U.S. patent. The approval is on a key divisional application for "Bonding of Soft Biological Tissues by Passing High Frequency Electric Current Therethrough" for CSMG Technologies subsidiary Live Tissue Connects ("LTC") platform tissue bonding/welding technology. The patent approval follows the issuance of four other U.S. patents, a European Union patent, in eight European countries, Ukraine, Canada and Australia with 14 U.S. and international patents pending. Donald S. Robbins, President and CEO of CSMG Technologies, said, "This key U.S. patent approval re-enforces our patent portfolio and expands LTC's commercial possibilities while increasing our shareholder value.

Examiner Made Two Legal Errors in Stem Cell Patent Decision, Consumer Advocates Say Appeal Brief Asks Wisconsin Alumni Research Foundation's Patent Claims Be Rejected

PRNewswire-USNewswire/ -- Legal papers just filed with the U.S. Patent Office cite two legal errors made by a patent examiner in confirming a patent on human embryonic stem cells and ask its claims be rejected, two consumer groups said today.

Examiner Made Two Legal Errors In Stem Cell Patent Decision, Consumer Advocates Say Appeal Brief Asks Wisconsin Alumni Research Foundation's Patent Claims Be Rejected

SANTA MONICA, CA -- Legal papers just filed with the U.S. Patent Office cite two legal errors made by a patent examiner in confirming a patent on human embryonic stem cells and ask its claims be rejected, two consumer groups said today.

Search took 0.20 seconds.